Prevalence and determinants of medication adherence among patients taking antihypertensive medications in Africa: A systematic review and meta‐analysis 2010–2021

This study synthesized the prevalence and determinants of hypertension medication adherence.

[1]  Bedasa Taye Merga,et al.  Adherence to antihypertensive medications and associated factors among hypertensive patients in Ethiopia: Systematic review and meta-analysis , 2020, SAGE Open Medicine.

[2]  N. Tan,et al.  Prevalence and factors associated with adherence to anti-hypertensives among adults with hypertension in a developed Asian community: A cross-sectional study , 2020, Proceedings of Singapore Healthcare.

[3]  C. Rotimi,et al.  Regional Patterns and Association Between Obesity and Hypertension in Africa , 2020, Hypertension.

[4]  V. Boima,et al.  Psycho-behavioural factors associated with medication adherence among male out-patients with hypertension in a Ghanaian hospital , 2020, PloS one.

[5]  Eric Adua,et al.  Prevalence and lifestyle-related risk factors of obesity and unrecognized hypertension among bus drivers in Ghana , 2020, Heliyon.

[6]  A. Odoi,et al.  Maternal and perinatal outcomes among women with hypertensive disorders in pregnancy in Kumasi, Ghana , 2019, PloS one.

[7]  N. Ramya,et al.  A study on usefulness of modified medication adherence scale in assessing adherence among hypertensive patients , 2019, Perspectives in clinical research.

[8]  Asgedom Solomon Weldegebreal,et al.  Assessment of drug therapy problem and associated factors among adult hypertensive patients at Ayder comprehensive specialized hospital, Northern Ethiopia , 2019, African health sciences.

[9]  O. Ilesanmi,et al.  Depression and medication-adherence in patients with hypertension attending a tertiary health facility in South-West Nigeria , 2019, The Pan African medical journal.

[10]  T. Mathes,et al.  Medication adherence influencing factors—an (updated) overview of systematic reviews , 2019, Systematic Reviews.

[11]  H. Yusuf,et al.  Validity evidence of adapted hausa version of 8-item Morisky medication adherence scale in patients with hypertension in North-Western Nigeria , 2019, Bayero Journal of Pure and Applied Sciences.

[12]  O. Adebayo,et al.  Medication adherence and 24-h blood pressure in apparently uncontrolled hypertensive Nigerian patients , 2019, The Nigerian postgraduate medical journal.

[13]  R. Adisa,et al.  Treatment adherence and blood pressure outcome among hypertensive out-patients in two tertiary hospitals in Sokoto, Northwestern Nigeria , 2018, BMC Cardiovascular Disorders.

[14]  L. Aminde,et al.  Non-adherence to antihypertensive pharmacotherapy in Buea, Cameroon: a cross-sectional community-based study , 2018, BMC Cardiovascular Disorders.

[15]  B. Godman,et al.  Evaluation of antihypertensive adherence and its determinants at primary healthcare facilities in rural South Africa. , 2018, Journal of comparative effectiveness research.

[16]  G. Asiki,et al.  Quantile regression analysis of modifiable and non-modifiable drivers’ of blood pressure among urban and rural women in Ghana , 2018, Scientific Reports.

[17]  L. Aminde,et al.  Prevalence and factors associated with medication adherence among patients with hypertension in sub-Saharan Africa: protocol for a systematic review and meta-analysis , 2018, BMJ Open.

[18]  S. Ofori-Acquah,et al.  Prevalence of relative systemic hypertension in adults with sickle cell disease in Ghana , 2018, PloS one.

[19]  Pierre Pluye,et al.  The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers , 2018, Educ. Inf..

[20]  C. Agyemang,et al.  Current trends in admissions and outcomes of cardiac diseases in Ghana , 2017, Clinical cardiology.

[21]  A. Awaisu,et al.  Factors associated with medication adherence among patients with diabetes in the Middle East and North Africa region: A systematic mixed studies review. , 2017, Diabetes research and clinical practice.

[22]  A. Gelagay,et al.  Medication adherence and its associated factors among hypertensive patients attending the Debre Tabor General Hospital, northwest Ethiopia , 2017, Integrated blood pressure control.

[23]  R. Akinyemi,et al.  Exploring Overlaps Between the Genomic and Environmental Determinants of LVH and Stroke : A Multicenter Study in West Africa , 2019 .

[24]  R. Califf,et al.  Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory Implications. , 2017, Journal of the American College of Cardiology.

[25]  A. Bhagavathula,et al.  Nonadherence to antihypertensive drugs , 2017, Medicine.

[26]  G. Mazur,et al.  Relationship between patients’ knowledge and medication adherence among patients with hypertension , 2016, Patient preference and adherence.

[27]  Rafal S. Sobota,et al.  Cardiovascular Disease Risk Factors in Ghana during the Rural-to-Urban Transition: A Cross-Sectional Study , 2016, PloS one.

[28]  Rafal S. Sobota,et al.  Plasminogen Activator Inhibitor‐1 and Diagnosis of the Metabolic Syndrome in a West African Population , 2016, Journal of the American Heart Association.

[29]  C. Obirikorang,et al.  Knowledge and Lifestyle-Associated Prevalence of Obesity among Newly Diagnosed Type II Diabetes Mellitus Patients Attending Diabetic Clinic at Komfo Anokye Teaching Hospital, Kumasi, Ghana: A Hospital-Based Cross-Sectional Study , 2016, Journal of diabetes research.

[30]  Jiang He,et al.  Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. , 2015, Circulation.

[31]  V. Conn,et al.  Interventions to Improve Medication Adherence in Hypertensive Patients: Systematic Review and Meta-analysis , 2015, Current Hypertension Reports.

[32]  D. Morisky,et al.  Adherence to Antihypertensives in Patients With Comorbid Condition , 2015, Nephro-urology monthly.

[33]  A. Kengne,et al.  Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-analysis. , 2015, Hypertension.

[34]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation , 2015, BMJ : British Medical Journal.

[35]  Davies Adeloye,et al.  An Estimate of the Incidence and Prevalence of Stroke in Africa: A Systematic Review and Meta-Analysis , 2014, PloS one.

[36]  Pierre Pluye,et al.  Combining the power of stories and the power of numbers: mixed methods research and mixed studies reviews. , 2014, Annual review of public health.

[37]  S. Danquah,et al.  Locus of control and anti-hypertensive medication adherence in Ghana , 2014, The Pan African medical journal.

[38]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[39]  Z. Mengesha,et al.  Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia , 2012, BMC Public Health.

[40]  D. Moher,et al.  Nonalcoholic Fatty Liver Disease and Acute Ischemic Stroke , 2010 .

[41]  B. Andrews,et al.  Factors Associated With Poor Medication Adherence In Hypertensive Patients In Lusaka, Zambia , 2010 .

[42]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.

[43]  Jay Hawkshead,et al.  Techniques for Measuring Medication Adherence in Hypertensive Patients in Outpatient Settings , 2007 .

[44]  A. L. Dal-Fabbro,et al.  Adherence to long term therapies: evidence for action , 2005 .

[45]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[46]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[47]  Y. Sakata.  Plasminogen activator inhibitor , 1986 .